ISCB45 (@iscb45) header
ISCB45 (@iscb45) profile picture

45th Annual Conference of the International Society for Clinical Biostatistics, 21-24 July 2024, Thessaloniki, Greece

Greece
Joined October 2019
Photo by ISCB45 (@iscb45)Photo by ISCB45 (@iscb45)Photo by ISCB45 (@iscb45)Photo by ISCB45 (@iscb45)Photo by ISCB45 (@iscb45)Photo by ISCB45 (@iscb45)Photo by ISCB45 (@iscb45)Photo by ISCB45 (@iscb45)Photo by ISCB45 (@iscb45)Photo by ISCB45 (@iscb45)
ISCB News Bulletin for September 2024 provides a recap of #ISCB45 in Thessaloniki, information about the upcoming #ISCB46 in Basel, and a reminder of the #ISCB ExCom Elections. canva.com/design/DAGP1DARynM…
2
1
8
439
If you are attending @ISCB45 conference in Greece, July 2024, check out the available pre-conf. courses. @MaxParmarMRCUCL& I will be delivering the MAMS platform trial design course. @MRCCTU @UKCTUNetwork @SCTorg @ICTM_UCL
Replying to @iscb45
Five pre-conference courses @KellyVanLancker @drizopoulos @BabakOskooei @CNakas and many others +invited sessions covering the stat of the art in biostatistics + an exciting social program (Mount Olympus, ancient Vergina, swimming etc).
5
8
1,091
5/5 Based on mathematical modelling, it is estimated that the proportion of the Greek population that was infected between mid February-end of April did not exceed 0.26%. Recent data from seroprevalence surveys in adults (blood donors, residual sera) corroborate this finding.
1
10
10
4/5 The reduction in R0 attributed to multiple social distancing measures implemented simultaneously was 81·0% (95%CrI: 71·8%, 86·0%). The reduction attributed to each measure separately (reduction of contacts at work, school, leisure activities) ranged between 10%-24%.
1
2
2
3/5 The effective reproduction number reached 0.46 (95% CrI: 0.35,0.57) during lockdown.
2
3
3
2/5 This was assessed using a social contacts survey in a sample of children and adults. The decline is similar to that estimated in two other surveys in China (science.sciencemag.org/conte…) and UK (adults only in UK) (bmcmedicine.biomedcentral.co…)
1
2
Main points presented in our preprint medrxiv.org/content/10.1101/… on the #COVID19 first epidemic wave in #Greece @VanaSypsa @dparask69 @STsiodras: 1/5During lockdown, the number of daily contacts was reduced by 86.9% as compared to pre-pandemic
2
16
1
27
BREAKING NEWS: Preliminary results of Spain's seroprevalence study #ENECOVID. >60,000 participants Antibodies for #SARSCoV2: 5% of Spanish population 11% in region with highest incidence (Madrid) So far from herd immunity in country with 2nd largest number of cases after U.S.
🔴EN DIRECTO Rueda de prensa del ministro de @sanidadgob, Salvador Illa, y el ministro de @CienciaGob, Pedro Duque, sobre la primera fase del Estudio Nacional Sero-Epidemiológico del #COVID19. #EsteVirusLoParamosUnidos teapawt.net/i/broadcasts/1lPJqVmqq…
96
1,352
408
2,112
The #USPSTF recommends screening for #HCV infection in adults aged 18 to 79 years. (B recommendation) ja.ma/2wlJ9BB
Updated list of countries on/off track to meet @WHO 2030 #HCV targets. On Track: 🇪🇬Egypt 🇫🇷France 🇮🇸Iceland 🇪🇸Spain 🇨🇭Switzerland Removed (mostly due to insufficient screening): 🇦🇺Australia 🇬🇪Georgia 🇮🇹Italy 🇯🇵Japan 🇲🇳Mongolia 🇳🇱Netherlands full list: tinyurl.com/t9rxs4d
3
21
5
25